NCT04930952View on ClinicalTrials.gov

Complications of Ethanol-amine Oleate Intralesional Sclerotherapy

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

February 28, 2019

Primary Completion Date

February 28, 2021

Study Completion Date

March 3, 2021

Conditions
Venous Malformation
Interventions
DRUG

Ethanol-amine Oleate Sclerotherapy Injection

Intralesional Sclerotherapy Injection

Trial Locations (1)

Unknown

Suez Canal University, Ismailia

All Listed Sponsors
lead

Suez Canal University

OTHER

NCT04930952 - Complications of Ethanol-amine Oleate Intralesional Sclerotherapy | Biotech Hunter | Biotech Hunter